Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits - PubMed (original) (raw)

Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits

F Gudat et al. Br J Pharmacol. 1981 Nov.

Abstract

1 Nerve growth factor (NGF), substance P (SP) and thymopoietin all caused shape change reactions of rapid onset in rabbit platelets. NGF had the highest maximal effect, and SP the lowest EC50 (concentration causing half maximal shape change). The action of SP was reversible within 5 min, whereas that of NGF lasted for at least 1 h. A series of other peptides were inactive. 2 After preincubation of platelets with SP, a second application of SP no longer caused a shape change reaction, whereas the effect of NGF was not influenced. 3 An oxidized NGF-derivative without biological activity did not cause a shape change reaction, neither did epidermal growth factor. 4 Prostaglandin E1 (PGE1) and pretreatment of the platelets with 3% butanol, which counteract the shape changes caused by 5-hydroxytryptamine (5-HT) and adenosine 3',5'-diphosphate, also antagonized those induced by NGF and SP. Neither heparin nor methysergide, an antagonist of 5-HT-receptors, influenced the shape change induced by NGF or SP. The action of NGF was also antagonized by a specific antibody to NGF. 5 Thymopoietin, like the basic polypeptide polyornithine (mol. wt. 40,000) was not antagonized by PGE1 and butanol. Heparin, which counteracted the effect of polyornithine, did not influence that of thymopoietin. 6 In conclusion, different modes of action are involved in the shape change of blood platelets induced by polypeptides and proteins. SP and NGF may act by stimulating specific membrane receptors.

PubMed Disclaimer

Similar articles

• Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
  Michal F, Motamed M. Michal F, et al. Br J Pharmacol. 1976 Feb;56(2):209-18. doi: 10.1111/j.1476-5381.1976.tb07444.x. Br J Pharmacol. 1976. PMID: 1252669 Free PMC article.
• Mutual antagonism between nerve growth factor and substance P N-terminal activity on nociceptive activity in mice.
  Larson AA, Kitto KF. Larson AA, et al. J Pharmacol Exp Ther. 1997 Sep;282(3):1345-50. J Pharmacol Exp Ther. 1997. PMID: 9316845
• Shape change of blood platelets brought about by myelin basic protein and other basic polypeptides.
  Laubscher A, Pletscher A, Honegger CG, Richards JG. Laubscher A, et al. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(1):87-92. doi: 10.1007/BF00499878. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 93703
• Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors.
  Born GV, Dearnley R, Foulks JG, Sharp DE. Born GV, et al. J Physiol. 1978 Jul;280:193-212. doi: 10.1113/jphysiol.1978.sp012380. J Physiol. 1978. PMID: 99512 Free PMC article.
• Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors?
  Graf M, Pletscher A. Graf M, et al. Br J Pharmacol. 1979 Apr;65(4):601-8. doi: 10.1111/j.1476-5381.1979.tb07870.x. Br J Pharmacol. 1979. PMID: 435685 Free PMC article.

Cited by

• Nerve growth factor induces growth and differentiation of human B lymphocytes.
  Otten U, Ehrhard P, Peck R. Otten U, et al. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10059-63. doi: 10.1073/pnas.86.24.10059. Proc Natl Acad Sci U S A. 1989. PMID: 2557615 Free PMC article.
• Neurotrophins and the immune system.
  Vega JA, García-Suárez O, Hannestad J, Pérez-Pérez M, Germanà A. Vega JA, et al. J Anat. 2003 Jul;203(1):1-19. doi: 10.1046/j.1469-7580.2003.00203.x. J Anat. 2003. PMID: 12892403 Free PMC article. Review.
• Expression of neurotrophins and their receptors in human bone marrow.
  Labouyrie E, Dubus P, Groppi A, Mahon FX, Ferrer J, Parrens M, Reiffers J, de Mascarel A, Merlio JP. Labouyrie E, et al. Am J Pathol. 1999 Feb;154(2):405-15. doi: 10.1016/S0002-9440(10)65287-X. Am J Pathol. 1999. PMID: 10027399 Free PMC article.
• Platelets as a model for neurones?
  Da Prada M, Cesura AM, Launay JM, Richards JG. Da Prada M, et al. Experientia. 1988 Feb 15;44(2):115-26. doi: 10.1007/BF01952193. Experientia. 1988. PMID: 2831073 Review.
• Expression of functional trk protooncogene in human monocytes.
  Ehrhard PB, Ganter U, Stalder A, Bauer J, Otten U. Ehrhard PB, et al. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5423-7. doi: 10.1073/pnas.90.12.5423. Proc Natl Acad Sci U S A. 1993. PMID: 8390664 Free PMC article.

References

1. 1. Proc Natl Acad Sci U S A. 1969 Oct;64(2):787-94 - PubMed
2. 1. Fed Proc. 1968 Jan-Feb;27(1):58-62 - PubMed
3. 1. J Physiol. 1970 Aug;209(2):487-511 - PubMed
4. 1. J Biol Chem. 1972 Dec 10;247(23):7609-11 - PubMed
5. 1. Biochem Pharmacol. 1973 Jun 1;22(11):1321-7 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Wiley